Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )

NCT07340723 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

GVHD,Acute
Stem Cell Transplant Complications

Interventions

DRUG: Ruxolitinib
DRUG: Corticosteroids

Sponsor

Daihong Liu